SciELO - Scientific Electronic Library Online

 
vol.26 número6Prevalencia de dolor crónico de cabeza, cervical y lumbar, y factores asociados, en mujeres residentes en la Comunidad de Madrid (España)El cuidado familiar prestado por mujeres inmigrantes y su repercusión en la calidad del cuidado y en la salud índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Gaceta Sanitaria

versão impressa ISSN 0213-9111

Resumo

GRUPO DE TRABAJO DE LA COHORTE VACH. Budget impact analysis of antiretroviral therapy: A reflection based on the GESIDA guidelines. Gac Sanit [online]. 2012, vol.26, n.6, pp.541-546. ISSN 0213-9111.  http://dx.doi.org/10.1016/j.gaceta.2012.01.015.

Objective: The latest version of the Spanish clinical practice guidelines on antiretroviral therapy (ART) in HIV-infected adults, developed by the Spanish AIDS Study Group (GESIDA) and the National AIDS Plan, recommends initiating ART early in certain circumstances. The aim of this study was to estimate the budget impact of this recommendation by using the data from the VACH cohort. Methods: We considered a scenario in which all naïve asymptomatic patients would initiate ART if they had <500 lymphocytes, or a CD4/µL count >500/µL if they were older than 55 years, or had high viral load, liver disease, chronic kidney disease or high cardiovascular risk. The study was designed as a cost analysis in terms of annual pharmaceutical expenditure. The only costs included were those relating to the ART combinations analyzed. To estimate these costs, we assumed that this guideline had a penetration of 80%, an adherence of 95% and 12% dropouts. Results: A total of 12,500 patients were reviewed. Of these, 1,127 (10%) had not initiated ART; CD4 lymphocyte count was 350-500 in 294 (26.1%) and > 500 in 685 (60.8%). If the new clinical practice guideline were applied, 45.2% of naïve patients (95% CI: 42.4%-48.2%) would be advised to start ART. Carrying out this recommendation in hospitals of the VACH cohort would require an additional annual investment of € 3,270,975 and would increase the overall cost of antiretroviral drugs by 3%. Conclusions: In the framework of health economics, incorporating economic impact estimates - such as those performed in this study - into clinical practice guidelines would be advisable to increase their feasibility.

Palavras-chave : Budget impact analysis; Costs and cost analysis; Clinical practice guidelines; HIV infection; Cohort studies.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons